KDM5B is a prognostic marker of triple-negative breast cancer (TNBC)

被引:0
|
作者
Almalki, N. [1 ]
Alsaleem, M. [2 ]
Rakha, E. [1 ]
Mongan, N. [1 ]
Allegrucci, C. [1 ]
机构
[1] Univ Nottingham, Nottingham, England
[2] Qassim Univ, Qasim, Saudi Arabia
来源
JOURNAL OF PATHOLOGY | 2023年 / 261卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P97
引用
收藏
页码:S37 / S37
页数:1
相关论文
共 50 条
  • [1] Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer
    I-Ju Yeh
    Emily Esakov
    Justin D. Lathia
    Masaru Miyagi
    Ofer Reizes
    Monica M. Montano
    Scientific Reports, 9
  • [2] Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer
    Yeh, I-Ju
    Esakov, Emily
    Lathia, Justin D.
    Miyagi, Masaru
    Reizes, Ofer
    Montano, Monica M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] Triple-negative breast cancer (TNBC) phosphoproteomics
    Gaitero, Sara Fernandez
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez-Lopez, Gonzalo
    Pisano, David Gonzalez
    Peralta, Javier Munoz
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    Quintela-Fandino, Miguel
    CANCER RESEARCH, 2017, 77
  • [4] Prognostic role of stem cell markers in triple-negative breast cancer (TNBC)
    Song, J.
    Apple, S.
    Goodglick, L.
    Mah, V. H.
    Kim, S. R.
    Alavi, M. T.
    Chia, D.
    Deng, X.
    Chang, H. R.
    CANCER RESEARCH, 2013, 73
  • [5] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [6] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [7] Phosphoproteomic portraits of triple-negative breast cancer (TNBC)
    Quintela-Fandino, Miguel
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez, Gonzalo
    Pisano, David G.
    Munoz, Javier
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [9] The Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer (TNBC)
    Shen, Tiansheng
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 72A - 72A
  • [10] Prognostic effect of beta blockers (BB) in triple-negative breast cancer (TNBC) patients
    Munzone, Elisabetta
    Botteri, Edoardo
    Rotmensz, Nicole
    Cipolla, Carlo Maria
    Zanelotti, Arnaldo
    Adamoli, Laura
    Viale, Giuseppe
    Goldhirsch, Aron
    Gandini, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)